| Dr Adrian Girald-rosa, MD | |
|
Carr 2 Bo Mora Km 111.3, Isabela, PR 00662 | |
| (787) 830-7737 | |
| (787) 830-7839 |
| Full Name | Dr Adrian Girald-rosa |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 25 Years |
| Location | Carr 2 Bo Mora Km 111.3, Isabela, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073758439 | NPI | - | NPPES |
| 037454300 | Medicaid | PR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 13930 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Policlinica Del Atlantico Corp | 7911801915 | 3 |
News Archive
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke.
The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.
VTT is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal includes planning individual lifestyle instructions for people at high risk of diabetes and exploiting the results in a major European health insurance system.
Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that scientists could use to develop more effective treatments and therapies for the chronic lung disorder.
Drug makers are bracing for reform by raising their prices - by 9 percent in the last year, perhaps the fastest rate since 1992, The New York Times reports. This happened "even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislation takes effect." The increases "will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year."
› Verified 5 days ago
| Entity Name | Policlinica Del Atlantico Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619074440 PECOS PAC ID: 7911801915 Enrollment ID: O20031121000282 |
News Archive
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke.
The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.
VTT is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal includes planning individual lifestyle instructions for people at high risk of diabetes and exploiting the results in a major European health insurance system.
Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that scientists could use to develop more effective treatments and therapies for the chronic lung disorder.
Drug makers are bracing for reform by raising their prices - by 9 percent in the last year, perhaps the fastest rate since 1992, The New York Times reports. This happened "even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislation takes effect." The increases "will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adrian Girald-rosa, MD 3623 Ave Militar, Pmb 226, Isabela, PR 00662-5802 Ph: (787) 830-7737 | Dr Adrian Girald-rosa, MD Carr 2 Bo Mora Km 111.3, Isabela, PR 00662 Ph: (787) 830-7737 |
News Archive
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke.
The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.
VTT is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal includes planning individual lifestyle instructions for people at high risk of diabetes and exploiting the results in a major European health insurance system.
Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that scientists could use to develop more effective treatments and therapies for the chronic lung disorder.
Drug makers are bracing for reform by raising their prices - by 9 percent in the last year, perhaps the fastest rate since 1992, The New York Times reports. This happened "even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislation takes effect." The increases "will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year."
› Verified 5 days ago
Dr. Huber A Tavarez Gonzalez, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr 474 Km 2.2, Bo Cotto, Isabela, PR 00662 Phone: 787-830-7472 | |
Dr. Juan Carlos Fantauzzi, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Carr 112 Int, Bo Bejucos Sect Florida, Isabela, PR 00662 Phone: 787-234-3729 | |
Dr. Isennia Marin, MD General Practice Medicare: Medicare Enrolled Practice Location: 414 Calle Copasu, Llanos De Isabela, Isabela, PR 00662 Phone: 787-207-6394 | |
Dr. Juan Manuel Corchado, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Carr 494 Km 1 He 1, Bo Arenales Altos, Isabela, PR 00662 Phone: 787-872-6281 | |
Dr. Hector Noel Vega Vega, General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr. 2 Int Km 112.6, Bo. Guerrero Sec. La Curva, Isabela, PR 00662 Phone: 787-872-2850 Fax: 787-872-2850 | |
Dr. David Hormoz Kalantar, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 7468 Calle Agustin Ramos Calero, Isabela, PR 00662 Phone: 787-830-6210 Fax: 787-830-6215 |